KalVista Pharmaceuticals Cash Flow Statement (2014-2025) | KALV

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jul2020	Oct2020	Jan2021	Apr2021	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Apr2025	Jul2025
Operating Activities
Net Income (Quarter)	-14.18M	-12.59M	-12.52M	-17.73M	-19.24M	-23.31M	-26.43M	-26.54M	-26.07M	-25.43M	-26.21M	-30.92M	-28.17M	-28.97M	-29.03M	29.33M	-40.44M	-44.45M	39.41M	-60.14M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	1.19M	1.25M	1.24M	3.44M	2.79M	2.86M	2.78M	2.65M	2.64M	2.51M	2.33M	2.44M	3.25M	3.21M	2.71M	2.20M	3.04M	3.00M	3.64M	5.38M
Gains from Investment Securities (Quarter)	0.07M	0.05M	0.08M	-0.04M	-0.02M	-0.10M	-0.18M	-0.28M	-0.02M	-0.07M	1.28M		0.31M	0.59M	0.22M	-0.97M	0.32M	-0.05M	0.37M	0.72M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)	-3.59M	-7.95M	-7.59M	-11.04M	-17.73M	-19.55M	-14.06M	-26.79M	-22.74M	-20.59M	-9.29M	-22.64M	-26.73M	-19.82M	-27.57M	-15.11M	-40.22M	-39.64M	-40.36M	-54.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.07M	0.07M	0.11M	0.44M	0.75M	0.67M	0.66M	0.48M	0.39M	0.29M	0.21M	0.10M	0.06M	0.02M	0.01M	0.00M	0.01M	0.01M	0.00M	-0.01M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.13M	0.13M	0.14M	0.14M	0.13M	0.13M	0.15M	0.16M	0.16M	0.17M	0.20M	0.17M	0.19M	0.20M	0.21M	0.20M	0.22M	0.23M	0.22M	0.25M
Change in Working Capital
Change in Receivables (Quarter)																				1.93M
Change in Account Payables (Quarter)	0.04M	0.41M	-1.63M	1.33M	-0.53M	1.69M	-0.94M	1.46M	-0.68M	0.60M	-1.83M	3.02M	0.11M	0.06M	-1.94M	6.10M	1.50M	-5.86M	-1.39M	2.51M
Change in Accured Expenses (Quarter)	0.54M	0.80M	-1.87M	1.52M	-1.00M	0.22M	0.51M	0.75M	-1.04M	1.03M	1.72M	0.23M	-1.24M	4.01M	2.87M	-2.44M	-1.78M	5.04M	8.12M	-8.20M
Other Working Capital Changes (Quarter)	-1.30M	-1.73M	3.00M	0.28M	0.62M	1.79M	1.24M	5.62M	-1.94M	-1.72M	-0.79M	-2.25M	1.00M	-1.76M	-0.14M	1.44M	0.78M	-2.10M	1.28M	0.49M
Investing Activities
Capital Expenditures (Quarter)	0.02M	0.01M	0.01M	0.03M	0.29M	0.36M	0.20M	0.09M	0.92M	0.19M	0.01M	0.07M	0.01M	0.00M	0.29M	-0.25M	0.06M	0.07M	0.34M	0.15M
Change in Acquisitions & Divestments (Quarter)	15.34M	15.92M	14.43M	7.95M	34.20M	50.66M	45.82M	65.03M	41.07M	20.29M	51.15M	28.35M	45.39M	32.53M	11.56M	15.48M	38.23M	48.88M	20.21M	41.68M
Cash from Investing Activities (Quarter)	5.51M	6.37M	6.95M	-166.48M	14.88M	17.64M	12.90M	12.43M	30.04M	20.10M	-2.52M	-6.21M	19.61M	28.56M	-6.70M	-126.19M	37.16M	48.67M	-3.33M	21.26M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	0.05M	0.06M	1.70M	210.31M	0.61M	0.06M	0.77M	0.14M	0.17M	0.17M	57.81M	-0.03M	0.20M	0.13M	0.28M	150.10M	3.00M	0.29M	4.66M	23.21M
Additional items
Exchange Rate Effect (Quarter)	0.25M	-0.32M	0.49M	0.09M	-0.00M	-0.01M	-0.52M	-0.63M	-0.34M	1.05M	0.46M	0.07M	0.08M	-0.60M	-0.62M	-0.07M	0.12M	0.41M	3.36M	2.72M
Change in Cash (Quarter)	2.23M	-1.84M	1.55M	32.87M	-2.25M	-1.85M	-0.91M	-14.85M	7.13M	0.72M	46.46M	-28.81M	-6.83M	8.26M	-34.61M	8.73M	0.06M	9.73M	-35.67M	-7.31M
Free Cash Flow (Quarter)	-3.61M	-7.96M	-7.60M	-11.08M	-18.02M	-19.90M	-14.27M	-26.88M	-23.66M	-20.79M	-9.30M	-22.70M	-26.74M	-19.83M	-27.86M	-14.85M	-40.28M	-39.71M	-40.71M	-54.65M
Net Cash Flow (Quarter)	1.97M	-1.52M	1.06M	32.78M	-2.25M	-1.84M	-0.39M	-14.22M	7.47M	-0.33M	46.01M	-28.88M	-6.91M	8.86M	-33.99M	8.81M	-0.06M	9.33M	-39.03M	-10.03M

Research Tools

KalVista Pharmaceuticals Cash Flow Statement (2014-2025) | KALV

Create an account

Sign In

Reset Password